These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 987908)

  • 1. D-penicillamine therapy in ABO hemolytic disease of the newborn infant.
    Lakatos L; Kövér B; Oroszlán G; Vekerdy Z
    Eur J Pediatr; 1976 Sep; 123(2):133-7. PubMed ID: 987908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
    Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S
    Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Penicillamine D therapy of hyperbilirubinemia in newborn infants. Preliminary report].
    Lakatos L; Kövér B
    Orv Hetil; 1974 Feb; 115(6):307-11. PubMed ID: 4209565
    [No Abstract]   [Full Text] [Related]  

  • 4. "Bloodless" treatment of a Jehovah's Witness infant with ABO hemolytic disease.
    Lakatos L; Csáthy L; Nemes E
    J Perinatol; 1999; 19(7):530-2. PubMed ID: 10685306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn.
    Nasseri F; Mamouri GA; Babaei H
    Saudi Med J; 2006 Dec; 27(12):1827-30. PubMed ID: 17143357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-penicillamine therapy of neonatal hyperbilirubinaemia.
    Lakatos L; Kövér B; Péter F
    Acta Paediatr Acad Sci Hung; 1974; 15(1):77-85. PubMed ID: 4211901
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of different blood components on exchange transfusion outcomes.
    Ghaemi S; Saneian H; Mo'ayedi B; Pourazar A
    J Pak Med Assoc; 2012 Mar; 62(3 Suppl 2):S45-8. PubMed ID: 22768458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indications for early exchange transfusion in patients with erythroblastosis fetalis.
    Wennberg RP; Depp R; Heinrichs WL
    J Pediatr; 1978 May; 92(5):789-92. PubMed ID: 565394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of transcutaneous method of bilirubin measurement in newborn population with the risk of ABO hemolytic disease.
    Stoniene D; Buinauskiene J; Markūniene E
    Medicina (Kaunas); 2009; 45(10):792-7. PubMed ID: 19996666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxyhemoglobin measurements in the diagnosis of ABO hemolytic disease.
    Uetani Y; Nakamura H; Okamoto O; Yamazaki T; Vreman HJ; Stevenson DK
    Acta Paediatr Jpn; 1989 Apr; 31(2):171-6. PubMed ID: 2516696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Penicillamine D therapy of hemolytic disease of newborn and neonatal hyperbilirubinemia].
    Lakatos L; Kövér B; Dvoracsek E; Vekerdy Z
    Orv Hetil; 1975 Aug; 116(32):1863-8. PubMed ID: 1170536
    [No Abstract]   [Full Text] [Related]  

  • 13. Exchange transfusion in newborn infants with perinatal hemolytic disease. Efficacy of the procedure.
    Ceccon ME; Diniz EM; Ramos JL; Vaz FA
    Rev Paul Med; 1993; 111(2):348-53. PubMed ID: 8284577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct hyperbilirubinemia complicating ABO hemolytic disease of the newborn.
    Sivan Y; Merlob P; Nutman J; Reisner SH
    Clin Pediatr (Phila); 1983 Aug; 22(8):537-8. PubMed ID: 6683136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-limited phototherapy of term newborns in ABO hemolytic disease and hyperbilirubinaemia.
    Rosta J; Makoi Z; Békefi D; Várady
    J Perinat Med; 1975; 3(3):198-203. PubMed ID: 1240143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABO hemolytic disease of the newborn. A retrospective analysis of 254 cases.
    Dufour DR; Monoghan WP
    Am J Clin Pathol; 1980 Mar; 73(3):369-73. PubMed ID: 7189092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of early interventions for ABO hemolytic disease of the newborn].
    Huang WM; Chen HW; Li N; Yang M; Jiao PY
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1350-1, 1355. PubMed ID: 16982453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence rate of ABO hemolytic disease of the newborn.
    Katz MA; Kanto WP; Korotkin JH
    Obstet Gynecol; 1982 May; 59(5):611-4. PubMed ID: 7070734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of intravenous immunoglobulin in the management of haemolytic disease of the newborn.
    Walsh SA; Yao N; El-Khuffash A; Twomey A; Molloy EJ
    Ir Med J; 2008 Feb; 101(2):46-8. PubMed ID: 18450249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.